Biotechnology Stocks I Performance Guide: Xenon Pharmaceuticals Inc. (XENE)
XENE has no dividends.
Table and Chart of XENE Performance
See what a $1,000 investment in XENE is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| XENE Returns | |
|---|---|
| Start Date | Dec-31-2014 |
| Start Price | $19.75 |
| End Date | Oct-11-2024 |
| End Price | $41.21 |
| # Prices | 119 |
| Min Date | Nov-30-2017 |
| Min Price | $2.45 |
| Max Date | Feb-29-2024 |
| Max Price | $47.20 |
| Total Return | 108.66% |
| Annualized Return | 7.70% |
| Current Value of $1,000 Purchase | $2,087 |
| Number Returns | 7,021 |
| Average Return | 193.69% |
| Number Profitable Returns | 5,689 |
| Percent Profitable Returns | 81.03% |
| Number Unprofitable Returns | 1,332 |
| Percent Unprofitable Returns | 18.97% |
| Profitable to Unprofitable Returns Ratio | 4.27 |
| XENE Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -11.810 | Price to Sales |
| Earnings per Share | $0.0000 |
| PE Ratio | -233680992 |
| PE to Growth Ratio | None |
| Price to Book | 181.44 |
| PRICE DATA | |
| 52 Week High | $1.25 |
| 52 Week Low | $50.99 |
| Analyst Target Price | $-1 |
| 50-Day Moving Average | $27.98 |
| 200-Day Moving Average | $39.88 |
| FINANCIAL DATA | |
| Revenue per Share | $-2.73 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -18.9% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
XENE Compare Returns with S&P 500
XENE Trendline Chart
XENE Moving Average Chart
XENE Stock Return Map - See Patterns of Gains and Losses
XENE Stock Returns/Purchase Dates